nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—SLC22A2—Cisplatin—urinary bladder cancer	0.17	0.415	CbGbCtD
Chlorphenamine—CYP3A4—Thiotepa—urinary bladder cancer	0.0982	0.24	CbGbCtD
Chlorphenamine—CYP3A5—Etoposide—urinary bladder cancer	0.0683	0.167	CbGbCtD
Chlorphenamine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0285	0.0697	CbGbCtD
Chlorphenamine—CYP3A4—Etoposide—urinary bladder cancer	0.0266	0.065	CbGbCtD
Chlorphenamine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0182	0.0443	CbGbCtD
Chlorphenamine—Confusional state—Mitomycin—urinary bladder cancer	0.0034	0.00864	CcSEcCtD
Chlorphenamine—Euphoric mood—Fluorouracil—urinary bladder cancer	0.00338	0.00858	CcSEcCtD
Chlorphenamine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00335	0.00851	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0033	0.00839	CcSEcCtD
Chlorphenamine—Urinary retention—Thiotepa—urinary bladder cancer	0.00328	0.00834	CcSEcCtD
Chlorphenamine—Photosensitivity—Fluorouracil—urinary bladder cancer	0.00325	0.00826	CcSEcCtD
Chlorphenamine—Dizziness—Valrubicin—urinary bladder cancer	0.00324	0.00823	CcSEcCtD
Chlorphenamine—Anorexia—Mitomycin—urinary bladder cancer	0.00321	0.00817	CcSEcCtD
Chlorphenamine—Vomiting—Valrubicin—urinary bladder cancer	0.00311	0.00791	CcSEcCtD
Chlorphenamine—Headache—Valrubicin—urinary bladder cancer	0.00307	0.00779	CcSEcCtD
Chlorphenamine—Somnolence—Mitomycin—urinary bladder cancer	0.003	0.00762	CcSEcCtD
Chlorphenamine—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.003	0.00761	CcSEcCtD
Chlorphenamine—Nasal congestion—Cisplatin—urinary bladder cancer	0.00297	0.00755	CcSEcCtD
Chlorphenamine—Decreased appetite—Mitomycin—urinary bladder cancer	0.00293	0.00745	CcSEcCtD
Chlorphenamine—Nausea—Valrubicin—urinary bladder cancer	0.00291	0.00739	CcSEcCtD
Chlorphenamine—Fatigue—Mitomycin—urinary bladder cancer	0.00291	0.00739	CcSEcCtD
Chlorphenamine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00278	0.00706	CcSEcCtD
Chlorphenamine—Irritability—Fluorouracil—urinary bladder cancer	0.00272	0.00692	CcSEcCtD
Chlorphenamine—Irritability—Cisplatin—urinary bladder cancer	0.00258	0.00656	CcSEcCtD
Chlorphenamine—Neuritis—Epirubicin—urinary bladder cancer	0.00256	0.00651	CcSEcCtD
Chlorphenamine—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00248	0.00631	CcSEcCtD
Chlorphenamine—Asthenia—Mitomycin—urinary bladder cancer	0.00242	0.00615	CcSEcCtD
Chlorphenamine—Hallucination—Thiotepa—urinary bladder cancer	0.00237	0.00604	CcSEcCtD
Chlorphenamine—Neuritis—Doxorubicin—urinary bladder cancer	0.00237	0.00603	CcSEcCtD
Chlorphenamine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00231	0.00586	CcSEcCtD
Chlorphenamine—Sweating increased—Cisplatin—urinary bladder cancer	0.00228	0.00579	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00225	0.00572	CcSEcCtD
Chlorphenamine—Dizziness—Mitomycin—urinary bladder cancer	0.00223	0.00567	CcSEcCtD
Chlorphenamine—Tinnitus—Thiotepa—urinary bladder cancer	0.00222	0.00566	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00219	0.00557	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00216	0.00548	CcSEcCtD
Chlorphenamine—Vomiting—Mitomycin—urinary bladder cancer	0.00214	0.00545	CcSEcCtD
Chlorphenamine—Chills—Thiotepa—urinary bladder cancer	0.00214	0.00544	CcSEcCtD
Chlorphenamine—Headache—Mitomycin—urinary bladder cancer	0.00211	0.00537	CcSEcCtD
Chlorphenamine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00209	0.0053	CcSEcCtD
Chlorphenamine—Sweating increased—Etoposide—urinary bladder cancer	0.00209	0.0053	CcSEcCtD
Chlorphenamine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00205	0.00522	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00204	0.00519	CcSEcCtD
Chlorphenamine—Tension—Thiotepa—urinary bladder cancer	0.00204	0.00518	CcSEcCtD
Chlorphenamine—Dyskinesia—Epirubicin—urinary bladder cancer	0.00204	0.00518	CcSEcCtD
Chlorphenamine—Nervousness—Thiotepa—urinary bladder cancer	0.00202	0.00513	CcSEcCtD
Chlorphenamine—Nausea—Mitomycin—urinary bladder cancer	0.002	0.00509	CcSEcCtD
Chlorphenamine—Vision blurred—Thiotepa—urinary bladder cancer	0.00196	0.00498	CcSEcCtD
Chlorphenamine—Agitation—Thiotepa—urinary bladder cancer	0.00191	0.00485	CcSEcCtD
Chlorphenamine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00188	0.00479	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00187	0.00476	CcSEcCtD
Chlorphenamine—Chills—Gemcitabine—urinary bladder cancer	0.0018	0.00458	CcSEcCtD
Chlorphenamine—Convulsion—Thiotepa—urinary bladder cancer	0.0018	0.00457	CcSEcCtD
Chlorphenamine—Hypertension—Thiotepa—urinary bladder cancer	0.00179	0.00456	CcSEcCtD
Chlorphenamine—Agranulocytosis—Etoposide—urinary bladder cancer	0.00178	0.00453	CcSEcCtD
Chlorphenamine—Anxiety—Thiotepa—urinary bladder cancer	0.00176	0.00448	CcSEcCtD
Chlorphenamine—Tinnitus—Cisplatin—urinary bladder cancer	0.00174	0.00443	CcSEcCtD
Chlorphenamine—Confusional state—Thiotepa—urinary bladder cancer	0.00171	0.00435	CcSEcCtD
Chlorphenamine—Photosensitivity—Methotrexate—urinary bladder cancer	0.00169	0.0043	CcSEcCtD
Chlorphenamine—Mental disability—Epirubicin—urinary bladder cancer	0.00166	0.00422	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00166	0.00422	CcSEcCtD
Chlorphenamine—Tachycardia—Thiotepa—urinary bladder cancer	0.00165	0.00421	CcSEcCtD
Chlorphenamine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00162	0.00412	CcSEcCtD
Chlorphenamine—Anorexia—Thiotepa—urinary bladder cancer	0.00162	0.00411	CcSEcCtD
Chlorphenamine—Photosensitivity—Epirubicin—urinary bladder cancer	0.00158	0.00402	CcSEcCtD
Chlorphenamine—Chills—Etoposide—urinary bladder cancer	0.00154	0.00391	CcSEcCtD
Chlorphenamine—Mental disability—Doxorubicin—urinary bladder cancer	0.00154	0.00391	CcSEcCtD
Chlorphenamine—Vision blurred—Cisplatin—urinary bladder cancer	0.00154	0.0039	CcSEcCtD
Chlorphenamine—Tremor—Cisplatin—urinary bladder cancer	0.00153	0.00388	CcSEcCtD
Chlorphenamine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00152	0.00387	CcSEcCtD
Chlorphenamine—Hypertension—Gemcitabine—urinary bladder cancer	0.00151	0.00383	CcSEcCtD
Chlorphenamine—Somnolence—Thiotepa—urinary bladder cancer	0.00151	0.00383	CcSEcCtD
Chlorphenamine—Dyspepsia—Thiotepa—urinary bladder cancer	0.00149	0.00379	CcSEcCtD
Chlorphenamine—Convulsion—Fluorouracil—urinary bladder cancer	0.00149	0.00378	CcSEcCtD
Chlorphenamine—Decreased appetite—Thiotepa—urinary bladder cancer	0.00147	0.00375	CcSEcCtD
Chlorphenamine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00146	0.00372	CcSEcCtD
Chlorphenamine—Fatigue—Thiotepa—urinary bladder cancer	0.00146	0.00372	CcSEcCtD
Chlorphenamine—Constipation—Thiotepa—urinary bladder cancer	0.00145	0.00369	CcSEcCtD
Chlorphenamine—Irritability—Methotrexate—urinary bladder cancer	0.00142	0.0036	CcSEcCtD
Chlorphenamine—Confusional state—Fluorouracil—urinary bladder cancer	0.00141	0.00359	CcSEcCtD
Chlorphenamine—Convulsion—Cisplatin—urinary bladder cancer	0.00141	0.00359	CcSEcCtD
Chlorphenamine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.0014	0.00355	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.0014	0.00355	CcSEcCtD
Chlorphenamine—Diplopia—Epirubicin—urinary bladder cancer	0.00139	0.00353	CcSEcCtD
Chlorphenamine—Anxiety—Cisplatin—urinary bladder cancer	0.00138	0.00351	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00138	0.0035	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00137	0.00349	CcSEcCtD
Chlorphenamine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00137	0.00348	CcSEcCtD
Chlorphenamine—Anorexia—Gemcitabine—urinary bladder cancer	0.00136	0.00346	CcSEcCtD
Chlorphenamine—Vertigo—Etoposide—urinary bladder cancer	0.00134	0.00341	CcSEcCtD
Chlorphenamine—Anorexia—Fluorouracil—urinary bladder cancer	0.00134	0.0034	CcSEcCtD
Chlorphenamine—Hypotension—Gemcitabine—urinary bladder cancer	0.00133	0.00339	CcSEcCtD
Chlorphenamine—Hypotension—Fluorouracil—urinary bladder cancer	0.00131	0.00333	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.0013	0.00331	CcSEcCtD
Chlorphenamine—Tachycardia—Cisplatin—urinary bladder cancer	0.0013	0.0033	CcSEcCtD
Chlorphenamine—Convulsion—Etoposide—urinary bladder cancer	0.00129	0.00329	CcSEcCtD
Chlorphenamine—Insomnia—Gemcitabine—urinary bladder cancer	0.00129	0.00328	CcSEcCtD
Chlorphenamine—Hypertension—Etoposide—urinary bladder cancer	0.00129	0.00327	CcSEcCtD
Chlorphenamine—Diplopia—Doxorubicin—urinary bladder cancer	0.00129	0.00327	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00129	0.00327	CcSEcCtD
Chlorphenamine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00128	0.00326	CcSEcCtD
Chlorphenamine—Insomnia—Fluorouracil—urinary bladder cancer	0.00127	0.00322	CcSEcCtD
Chlorphenamine—Somnolence—Gemcitabine—urinary bladder cancer	0.00127	0.00322	CcSEcCtD
Chlorphenamine—Anorexia—Cisplatin—urinary bladder cancer	0.00127	0.00322	CcSEcCtD
Chlorphenamine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00126	0.0032	CcSEcCtD
Chlorphenamine—Somnolence—Fluorouracil—urinary bladder cancer	0.00125	0.00317	CcSEcCtD
Chlorphenamine—Hypotension—Cisplatin—urinary bladder cancer	0.00124	0.00316	CcSEcCtD
Chlorphenamine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00124	0.00315	CcSEcCtD
Chlorphenamine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00123	0.00314	CcSEcCtD
Chlorphenamine—Fatigue—Gemcitabine—urinary bladder cancer	0.00123	0.00313	CcSEcCtD
Chlorphenamine—Confusional state—Etoposide—urinary bladder cancer	0.00123	0.00312	CcSEcCtD
Chlorphenamine—Constipation—Gemcitabine—urinary bladder cancer	0.00122	0.0031	CcSEcCtD
Chlorphenamine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00122	0.0031	CcSEcCtD
Chlorphenamine—Asthenia—Thiotepa—urinary bladder cancer	0.00122	0.00309	CcSEcCtD
Chlorphenamine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00119	0.00303	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00119	0.00303	CcSEcCtD
Chlorphenamine—Tachycardia—Etoposide—urinary bladder cancer	0.00119	0.00302	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00118	0.00299	CcSEcCtD
Chlorphenamine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00118	0.00299	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00117	0.00298	CcSEcCtD
Chlorphenamine—Anorexia—Etoposide—urinary bladder cancer	0.00116	0.00295	CcSEcCtD
Chlorphenamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00116	0.00295	CcSEcCtD
Chlorphenamine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00116	0.00294	CcSEcCtD
Chlorphenamine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00116	0.00294	CcSEcCtD
Chlorphenamine—Drowsiness—Methotrexate—urinary bladder cancer	0.00114	0.00291	CcSEcCtD
Chlorphenamine—Hypotension—Etoposide—urinary bladder cancer	0.00114	0.00289	CcSEcCtD
Chlorphenamine—Dizziness—Thiotepa—urinary bladder cancer	0.00112	0.00285	CcSEcCtD
Chlorphenamine—Pollakiuria—Epirubicin—urinary bladder cancer	0.00111	0.00282	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.0011	0.00279	CcSEcCtD
Chlorphenamine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.0011	0.00278	CcSEcCtD
Chlorphenamine—Paraesthesia—Etoposide—urinary bladder cancer	0.00109	0.00278	CcSEcCtD
Chlorphenamine—Somnolence—Etoposide—urinary bladder cancer	0.00108	0.00275	CcSEcCtD
Chlorphenamine—Vomiting—Thiotepa—urinary bladder cancer	0.00108	0.00274	CcSEcCtD
Chlorphenamine—Drowsiness—Epirubicin—urinary bladder cancer	0.00107	0.00272	CcSEcCtD
Chlorphenamine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00107	0.00271	CcSEcCtD
Chlorphenamine—Headache—Thiotepa—urinary bladder cancer	0.00106	0.0027	CcSEcCtD
Chlorphenamine—Decreased appetite—Etoposide—urinary bladder cancer	0.00106	0.00269	CcSEcCtD
Chlorphenamine—Fatigue—Etoposide—urinary bladder cancer	0.00105	0.00267	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00105	0.00267	CcSEcCtD
Chlorphenamine—Constipation—Etoposide—urinary bladder cancer	0.00104	0.00265	CcSEcCtD
Chlorphenamine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00103	0.00261	CcSEcCtD
Chlorphenamine—Asthenia—Gemcitabine—urinary bladder cancer	0.00102	0.0026	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00101	0.00258	CcSEcCtD
Chlorphenamine—Nausea—Thiotepa—urinary bladder cancer	0.00101	0.00256	CcSEcCtD
Chlorphenamine—Feeling abnormal—Etoposide—urinary bladder cancer	0.001	0.00255	CcSEcCtD
Chlorphenamine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000999	0.00254	CcSEcCtD
Chlorphenamine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00099	0.00252	CcSEcCtD
Chlorphenamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000976	0.00248	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000971	0.00247	CcSEcCtD
Chlorphenamine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000959	0.00244	CcSEcCtD
Chlorphenamine—Tinnitus—Methotrexate—urinary bladder cancer	0.000957	0.00243	CcSEcCtD
Chlorphenamine—Asthenia—Cisplatin—urinary bladder cancer	0.000954	0.00242	CcSEcCtD
Chlorphenamine—Dizziness—Fluorouracil—urinary bladder cancer	0.000927	0.00236	CcSEcCtD
Chlorphenamine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000924	0.00235	CcSEcCtD
Chlorphenamine—Chills—Methotrexate—urinary bladder cancer	0.000921	0.00234	CcSEcCtD
Chlorphenamine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00091	0.00231	CcSEcCtD
Chlorphenamine—Vomiting—Gemcitabine—urinary bladder cancer	0.000907	0.0023	CcSEcCtD
Chlorphenamine—Tinnitus—Epirubicin—urinary bladder cancer	0.000896	0.00228	CcSEcCtD
Chlorphenamine—Headache—Gemcitabine—urinary bladder cancer	0.000893	0.00227	CcSEcCtD
Chlorphenamine—Vomiting—Fluorouracil—urinary bladder cancer	0.000892	0.00227	CcSEcCtD
Chlorphenamine—Headache—Fluorouracil—urinary bladder cancer	0.000878	0.00223	CcSEcCtD
Chlorphenamine—Asthenia—Etoposide—urinary bladder cancer	0.000874	0.00222	CcSEcCtD
Chlorphenamine—Chills—Epirubicin—urinary bladder cancer	0.000862	0.00219	CcSEcCtD
Chlorphenamine—Nausea—Gemcitabine—urinary bladder cancer	0.000847	0.00215	CcSEcCtD
Chlorphenamine—Vomiting—Cisplatin—urinary bladder cancer	0.000845	0.00215	CcSEcCtD
Chlorphenamine—Vision blurred—Methotrexate—urinary bladder cancer	0.000842	0.00214	CcSEcCtD
Chlorphenamine—Diarrhoea—Etoposide—urinary bladder cancer	0.000833	0.00212	CcSEcCtD
Chlorphenamine—Nausea—Fluorouracil—urinary bladder cancer	0.000833	0.00212	CcSEcCtD
Chlorphenamine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000829	0.00211	CcSEcCtD
Chlorphenamine—Tension—Epirubicin—urinary bladder cancer	0.000821	0.00209	CcSEcCtD
Chlorphenamine—Nervousness—Epirubicin—urinary bladder cancer	0.000812	0.00206	CcSEcCtD
Chlorphenamine—Dizziness—Etoposide—urinary bladder cancer	0.000805	0.00205	CcSEcCtD
Chlorphenamine—Vertigo—Methotrexate—urinary bladder cancer	0.000803	0.00204	CcSEcCtD
Chlorphenamine—Chills—Doxorubicin—urinary bladder cancer	0.000798	0.00203	CcSEcCtD
Chlorphenamine—Nausea—Cisplatin—urinary bladder cancer	0.00079	0.00201	CcSEcCtD
Chlorphenamine—Vision blurred—Epirubicin—urinary bladder cancer	0.000788	0.002	CcSEcCtD
Chlorphenamine—Convulsion—Methotrexate—urinary bladder cancer	0.000774	0.00197	CcSEcCtD
Chlorphenamine—Vomiting—Etoposide—urinary bladder cancer	0.000774	0.00197	CcSEcCtD
Chlorphenamine—Agitation—Epirubicin—urinary bladder cancer	0.000769	0.00195	CcSEcCtD
Chlorphenamine—Headache—Etoposide—urinary bladder cancer	0.000763	0.00194	CcSEcCtD
Chlorphenamine—Tension—Doxorubicin—urinary bladder cancer	0.000759	0.00193	CcSEcCtD
Chlorphenamine—Nervousness—Doxorubicin—urinary bladder cancer	0.000752	0.00191	CcSEcCtD
Chlorphenamine—Vertigo—Epirubicin—urinary bladder cancer	0.000751	0.00191	CcSEcCtD
Chlorphenamine—Palpitations—Epirubicin—urinary bladder cancer	0.000739	0.00188	CcSEcCtD
Chlorphenamine—Confusional state—Methotrexate—urinary bladder cancer	0.000736	0.00187	CcSEcCtD
Chlorphenamine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000729	0.00185	CcSEcCtD
Chlorphenamine—Convulsion—Epirubicin—urinary bladder cancer	0.000725	0.00184	CcSEcCtD
Chlorphenamine—Nausea—Etoposide—urinary bladder cancer	0.000723	0.00184	CcSEcCtD
Chlorphenamine—Hypertension—Epirubicin—urinary bladder cancer	0.000722	0.00184	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000714	0.00182	CcSEcCtD
Chlorphenamine—Agitation—Doxorubicin—urinary bladder cancer	0.000711	0.00181	CcSEcCtD
Chlorphenamine—Anxiety—Epirubicin—urinary bladder cancer	0.00071	0.0018	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000705	0.00179	CcSEcCtD
Chlorphenamine—Dry mouth—Epirubicin—urinary bladder cancer	0.000696	0.00177	CcSEcCtD
Chlorphenamine—Vertigo—Doxorubicin—urinary bladder cancer	0.000695	0.00177	CcSEcCtD
Chlorphenamine—Anorexia—Methotrexate—urinary bladder cancer	0.000695	0.00177	CcSEcCtD
Chlorphenamine—Confusional state—Epirubicin—urinary bladder cancer	0.000688	0.00175	CcSEcCtD
Chlorphenamine—Palpitations—Doxorubicin—urinary bladder cancer	0.000684	0.00174	CcSEcCtD
Chlorphenamine—Hypotension—Methotrexate—urinary bladder cancer	0.000682	0.00173	CcSEcCtD
Chlorphenamine—Convulsion—Doxorubicin—urinary bladder cancer	0.000671	0.0017	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000668	0.0017	CcSEcCtD
Chlorphenamine—Hypertension—Doxorubicin—urinary bladder cancer	0.000668	0.0017	CcSEcCtD
Chlorphenamine—Tachycardia—Epirubicin—urinary bladder cancer	0.000666	0.00169	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00066	0.00168	CcSEcCtD
Chlorphenamine—Insomnia—Methotrexate—urinary bladder cancer	0.00066	0.00168	CcSEcCtD
Chlorphenamine—Anxiety—Doxorubicin—urinary bladder cancer	0.000657	0.00167	CcSEcCtD
Chlorphenamine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000655	0.00166	CcSEcCtD
Chlorphenamine—Anorexia—Epirubicin—urinary bladder cancer	0.000651	0.00165	CcSEcCtD
Chlorphenamine—Somnolence—Methotrexate—urinary bladder cancer	0.000648	0.00165	CcSEcCtD
Chlorphenamine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000644	0.00164	CcSEcCtD
Chlorphenamine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000642	0.00163	CcSEcCtD
Chlorphenamine—Hypotension—Epirubicin—urinary bladder cancer	0.000638	0.00162	CcSEcCtD
Chlorphenamine—Confusional state—Doxorubicin—urinary bladder cancer	0.000637	0.00162	CcSEcCtD
Chlorphenamine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000634	0.00161	CcSEcCtD
Chlorphenamine—Fatigue—Methotrexate—urinary bladder cancer	0.000629	0.0016	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000618	0.00157	CcSEcCtD
Chlorphenamine—Insomnia—Epirubicin—urinary bladder cancer	0.000617	0.00157	CcSEcCtD
Chlorphenamine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000616	0.00157	CcSEcCtD
Chlorphenamine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000613	0.00156	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000611	0.00155	CcSEcCtD
Chlorphenamine—Somnolence—Epirubicin—urinary bladder cancer	0.000607	0.00154	CcSEcCtD
Chlorphenamine—Anorexia—Doxorubicin—urinary bladder cancer	0.000602	0.00153	CcSEcCtD
Chlorphenamine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000601	0.00153	CcSEcCtD
Chlorphenamine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000601	0.00153	CcSEcCtD
Chlorphenamine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000593	0.00151	CcSEcCtD
Chlorphenamine—Hypotension—Doxorubicin—urinary bladder cancer	0.00059	0.0015	CcSEcCtD
Chlorphenamine—Fatigue—Epirubicin—urinary bladder cancer	0.000589	0.0015	CcSEcCtD
Chlorphenamine—Constipation—Epirubicin—urinary bladder cancer	0.000584	0.00148	CcSEcCtD
Chlorphenamine—Insomnia—Doxorubicin—urinary bladder cancer	0.000571	0.00145	CcSEcCtD
Chlorphenamine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000567	0.00144	CcSEcCtD
Chlorphenamine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000563	0.00143	CcSEcCtD
Chlorphenamine—Somnolence—Doxorubicin—urinary bladder cancer	0.000562	0.00143	CcSEcCtD
Chlorphenamine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000556	0.00141	CcSEcCtD
Chlorphenamine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000549	0.0014	CcSEcCtD
Chlorphenamine—Fatigue—Doxorubicin—urinary bladder cancer	0.000545	0.00138	CcSEcCtD
Chlorphenamine—Constipation—Doxorubicin—urinary bladder cancer	0.00054	0.00137	CcSEcCtD
Chlorphenamine—Asthenia—Methotrexate—urinary bladder cancer	0.000523	0.00133	CcSEcCtD
Chlorphenamine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000521	0.00132	CcSEcCtD
Chlorphenamine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000499	0.00127	CcSEcCtD
Chlorphenamine—Asthenia—Epirubicin—urinary bladder cancer	0.00049	0.00124	CcSEcCtD
Chlorphenamine—Dizziness—Methotrexate—urinary bladder cancer	0.000482	0.00123	CcSEcCtD
Chlorphenamine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000467	0.00119	CcSEcCtD
Chlorphenamine—Vomiting—Methotrexate—urinary bladder cancer	0.000464	0.00118	CcSEcCtD
Chlorphenamine—Headache—Methotrexate—urinary bladder cancer	0.000457	0.00116	CcSEcCtD
Chlorphenamine—Asthenia—Doxorubicin—urinary bladder cancer	0.000453	0.00115	CcSEcCtD
Chlorphenamine—Dizziness—Epirubicin—urinary bladder cancer	0.000451	0.00115	CcSEcCtD
Chlorphenamine—Vomiting—Epirubicin—urinary bladder cancer	0.000434	0.0011	CcSEcCtD
Chlorphenamine—Nausea—Methotrexate—urinary bladder cancer	0.000433	0.0011	CcSEcCtD
Chlorphenamine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000432	0.0011	CcSEcCtD
Chlorphenamine—Headache—Epirubicin—urinary bladder cancer	0.000428	0.00109	CcSEcCtD
Chlorphenamine—Dizziness—Doxorubicin—urinary bladder cancer	0.000418	0.00106	CcSEcCtD
Chlorphenamine—Nausea—Epirubicin—urinary bladder cancer	0.000405	0.00103	CcSEcCtD
Chlorphenamine—Vomiting—Doxorubicin—urinary bladder cancer	0.000402	0.00102	CcSEcCtD
Chlorphenamine—Headache—Doxorubicin—urinary bladder cancer	0.000396	0.00101	CcSEcCtD
Chlorphenamine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000376	0.00191	CbGpPWpGaD
Chlorphenamine—Nausea—Doxorubicin—urinary bladder cancer	0.000375	0.000954	CcSEcCtD
Chlorphenamine—HRH1—IL-4 Signaling Pathway—EP300—urinary bladder cancer	0.000375	0.0019	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000374	0.0019	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000369	0.00187	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000367	0.00186	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.000366	0.00186	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000361	0.00183	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00036	0.00183	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000356	0.00181	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000334	0.00169	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000332	0.00169	CbGpPWpGaD
Chlorphenamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000322	0.00164	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000319	0.00162	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000312	0.00158	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000304	0.00155	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000295	0.0015	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000291	0.00148	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000288	0.00146	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000284	0.00144	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000271	0.00138	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000267	0.00136	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000265	0.00134	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000261	0.00133	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000249	0.00126	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000246	0.00125	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000244	0.00124	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTZ1—urinary bladder cancer	0.000244	0.00124	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000243	0.00124	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000231	0.00117	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000231	0.00117	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	0.000231	0.00117	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NAT1—urinary bladder cancer	0.000231	0.00117	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000229	0.00116	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTZ1—urinary bladder cancer	0.000227	0.00115	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—EP300—urinary bladder cancer	0.000218	0.00111	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000217	0.0011	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000216	0.0011	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTO2—urinary bladder cancer	0.000215	0.00109	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NAT1—urinary bladder cancer	0.000215	0.00109	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000212	0.00107	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	0.000211	0.00107	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000205	0.00104	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000202	0.00103	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000199	0.00101	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—UGT2B7—urinary bladder cancer	0.000197	0.001	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000196	0.000997	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000193	0.000981	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.00019	0.000967	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	0.00019	0.000966	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000188	0.000955	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000186	0.000942	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000183	0.000929	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.00018	0.000913	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	0.00018	0.000912	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CYP4B1—urinary bladder cancer	0.000177	0.0009	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000176	0.000896	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000175	0.00089	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	0.000175	0.000889	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SLC19A1—urinary bladder cancer	0.000167	0.00085	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000167	0.000849	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000167	0.000849	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PRSS3—urinary bladder cancer	0.000163	0.000828	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—TP53—urinary bladder cancer	0.000156	0.000793	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000153	0.000777	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.00014	0.000712	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TYMP—urinary bladder cancer	0.00014	0.000711	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000138	0.000699	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000134	0.00068	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000132	0.00067	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TYMP—urinary bladder cancer	0.00013	0.000662	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.00013	0.00066	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000127	0.000644	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000127	0.000643	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NAT2—urinary bladder cancer	0.000127	0.000643	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000125	0.000637	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000123	0.000625	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000121	0.000616	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000121	0.000614	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000119	0.000604	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000119	0.000604	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NAT2—urinary bladder cancer	0.000118	0.000599	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000114	0.00058	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000114	0.000579	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	0.000109	0.000556	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—RRM2—urinary bladder cancer	0.000109	0.000555	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000109	0.000552	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000107	0.000545	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000106	0.000538	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000104	0.000528	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—RRM2—urinary bladder cancer	0.000102	0.000517	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	0.000101	0.000515	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	0.000101	0.000514	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	0.000101	0.000514	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.000101	0.000514	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ENO2—urinary bladder cancer	0.000101	0.000514	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	0.000101	0.000514	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000101	0.000513	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.0001	0.000508	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	9.83e-05	0.000499	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	9.81e-05	0.000498	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	9.79e-05	0.000497	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.69e-05	0.000492	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ENO2—urinary bladder cancer	9.43e-05	0.000479	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	9.43e-05	0.000479	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	9.24e-05	0.000469	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.18e-05	0.000466	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	9.16e-05	0.000465	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	9.14e-05	0.000464	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	9.01e-05	0.000458	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	8.75e-05	0.000444	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.56e-05	0.000435	CbGpPWpGaD
Chlorphenamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	8.5e-05	0.000432	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	8.2e-05	0.000416	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	8.17e-05	0.000415	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	8.17e-05	0.000415	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	8.15e-05	0.000414	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	7.96e-05	0.000404	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	7.91e-05	0.000402	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.77e-05	0.000395	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.77e-05	0.000395	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NQO1—urinary bladder cancer	7.6e-05	0.000386	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	7.42e-05	0.000377	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	7.32e-05	0.000372	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	7.32e-05	0.000372	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	7.2e-05	0.000366	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	7.11e-05	0.000361	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	7.1e-05	0.000361	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	6.95e-05	0.000353	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	6.81e-05	0.000346	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	6.8e-05	0.000345	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	6.53e-05	0.000332	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	6.51e-05	0.000331	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.4e-05	0.000325	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	6.34e-05	0.000322	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	6.33e-05	0.000322	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	6.32e-05	0.000321	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	6.26e-05	0.000318	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	6.26e-05	0.000318	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	6.25e-05	0.000317	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	6.25e-05	0.000317	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	6.22e-05	0.000316	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	6.04e-05	0.000307	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	5.99e-05	0.000304	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	5.98e-05	0.000304	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.9e-05	0.0003	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	5.89e-05	0.000299	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.89e-05	0.000299	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	5.88e-05	0.000299	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	5.88e-05	0.000298	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	5.82e-05	0.000296	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	5.82e-05	0.000296	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.62e-05	0.000286	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	5.58e-05	0.000283	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	5.53e-05	0.000281	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	5.52e-05	0.00028	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	5.48e-05	0.000278	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	5.26e-05	0.000267	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.21e-05	0.000264	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.21e-05	0.000264	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	5.15e-05	0.000261	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.05e-05	0.000256	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	5.04e-05	0.000256	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.92e-05	0.00025	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	4.77e-05	0.000242	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.71e-05	0.000239	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.61e-05	0.000234	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.58e-05	0.000232	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	4.53e-05	0.00023	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.52e-05	0.00023	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.52e-05	0.00023	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.49e-05	0.000228	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	4.48e-05	0.000227	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	4.41e-05	0.000224	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.33e-05	0.00022	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.31e-05	0.000219	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	4.3e-05	0.000218	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.26e-05	0.000216	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.25e-05	0.000216	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.2e-05	0.000213	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.19e-05	0.000213	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	4.17e-05	0.000212	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	4.01e-05	0.000204	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	4e-05	0.000203	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4e-05	0.000203	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	3.99e-05	0.000203	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.68e-05	0.000187	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	3.66e-05	0.000186	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	3.56e-05	0.000181	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.53e-05	0.000179	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	3.52e-05	0.000179	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.5e-05	0.000178	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.4e-05	0.000173	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.4e-05	0.000173	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.3e-05	0.000168	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	3.28e-05	0.000167	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.25e-05	0.000165	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.24e-05	0.000165	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.22e-05	0.000163	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.22e-05	0.000163	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	3.12e-05	0.000158	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.11e-05	0.000158	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.08e-05	0.000156	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	3.08e-05	0.000156	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.08e-05	0.000156	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	3.07e-05	0.000156	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	3.06e-05	0.000156	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.02e-05	0.000154	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.93e-05	0.000149	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—EP300—urinary bladder cancer	2.93e-05	0.000149	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	2.89e-05	0.000147	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	2.86e-05	0.000145	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.84e-05	0.000144	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	2.82e-05	0.000143	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.74e-05	0.000139	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—EP300—urinary bladder cancer	2.73e-05	0.000139	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	2.61e-05	0.000133	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.55e-05	0.00013	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	2.48e-05	0.000126	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	2.46e-05	0.000125	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	2.37e-05	0.00012	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	2.31e-05	0.000117	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.31e-05	0.000117	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.29e-05	0.000116	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	2.24e-05	0.000114	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.23e-05	0.000113	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	2.23e-05	0.000113	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.22e-05	0.000113	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.21e-05	0.000112	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.13e-05	0.000108	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	2.12e-05	0.000108	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.12e-05	0.000108	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000107	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000107	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	2.06e-05	0.000105	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000102	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.98e-05	0.0001	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.86e-05	9.44e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.85e-05	9.39e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.81e-05	9.21e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.81e-05	9.19e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.71e-05	8.68e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.58e-05	8.03e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	1.52e-05	7.72e-05	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.51e-05	7.66e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.51e-05	7.65e-05	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	1.45e-05	7.38e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.45e-05	7.35e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.19e-05	6.02e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.03e-05	5.25e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.86e-06	5.01e-05	CbGpPWpGaD
